Category: Innovative Discoveries Series

IDS: Law, Technology, and End-of-life Planning

Innovative Discoveries Series Law, Technology, and End-of-life Planning December 14, 2018 from 12:00-1:00 pm In-person: Christiana Hospital, room 1100 On-line: Watch live at https://bluejeans.com/361095905 Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet This activity has been approved for AMA PRA Category 1 Credit RSVP Watch Live Subscribe Advance directives (AD) […]

Innovation Discoveries Series

Statin Use is Associated with Lower Osteoarthritis Occurrence in the Delaware Population November 30, 2018 from 12:00-1:00 pm In-person: Christiana Hospital, Ammon Back Auditorium On-line: Watch live at https://bluejeans.com/361095905 Or join meeting ID 361095905 on the BlueJeans app on your smartphone or tablet This activity has been approved for AMA PRA Category 1 Credit   Statins […]

Tech Talk: Complex Models to Understand Complex Health Behaviors

Tech Talk – Complex Models to Understand Complex Health Behaviors Mediator – Zugui Zhang 12noon -1 pm  

Innovative Discoveries Series: Living laboratories: Building Clinical Programs with Impact

Innovative Discoveries Series presented by Dr. Charmaine Wright will be held in Christiana Hospital Back Auditorium at noon, and is titled “Living laboratories: Building Clinical Programs with Impact.”  You can also watch live at https://bluejeans.com/361095905. CME credit is available for in-person attendance. If you have not done so, please register now.   There is a […]

Mixed-Methods with Teens: A Research Imperative

Mixed-methods research and adolescent males aren’t often paired in the same sentence. However, they could – and should – be! Join Dr. Judith Herrman and Katie Haigh from the University of Delaware and Christopher Moore from the Department of Family and Community Medicine as they present their research evaluating the impact of the Wise Guys […]

Fear, Vulnerability, and Sacrifice as Factors in ED Use: Ethnographic Research Methods and their Insights

Ethnographic research and social analyses in healthcare settings have long been valued, however their use is not widespread. Qualitative research about patient-centered care makes patients the experts, and providers, policy makers and administrators the students. In this presentation, I discuss a 2015 case study of a 51-year-old low-income Philadelphia man who had two ED visits […]

Single Molecule DNA and RNA Sequencing to Detect Residual Cancer and Clonal Hematopoiesis

Dr. Druley will discuss novel strategies for single molecule DNA and RNA sequencing as a modality for characterization of clonal hematopoiesis and minimal residual disease (MRD) detection in cancer. Despite “deep sequencing,” next-generation platforms have an error rate of 0.5-1.0%, precluding straightforward sequencing for MRD, which requires sensitivity of less than 1:1,000. However, using a […]

Field Trials in Developing Countries: Lessons from the PURE Study

The PURE study assesses environmental, societal, and biological influences on obesity and chronic health conditions such as heart disease, diabetes, and cancer. This presentation will describe the setup and execution of this large and complex study; key findings to date; and the possibilities and pitfalls of field-based data collection in developing countries. Dr. Rahman is […]

Endothelial Function in Relatively Healthy Persons: Studies of the Old Order Amish

Endothelial cells are the first layer response to atherosclerotic risk factors. In clinically healthy individuals with no overt disease, Laser Doppler Flowmetry is used to evaluate endothelial function. This presentation will review endothelial cell response to clopidogrel and clopidogrels activation in the body. Last, we will review genetic determinants of endothelial growth factor angiopoietin-2, a […]

Differences in Patient and Physician Perceptions of Care for Patients with Myeloproliferative Neoplasms

This talk will focus on data collected from the Landmark Survey, a large survey of patients with myeloproliferative neoplasms (MPNs, namely essential thrombocytosis, primary myelofibrosis, and polycythemia vera) and the providers who take care of patients with MPNs. The Landmark Survey focused on quality of life issues surrounding the diagnosis of MPNs and differences in […]